Nouvelle déclaration d'incident
No de la demande: 2009-4282
Numéro de référence du titulaire d'homologation: Prosar 1-19644779
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Crop Protection Canada, Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez l'humain
Pays: UNITED STATES
État: LOUISIANA
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: non-specific Demon (Cypermethrin-based insecticide)
Liquide
Oui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Inconnu
Professionnel de la santé
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Non professionnel
Contact avec la zone traitée
Temps écoulé entre l'application et l'exposition (contact) 8
Hour(s) / Heure(s)
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
1-19644779: A reporter (physician) called on 08/26/2009 to report the exposure of a patient to an insecticide containing the active ingredient Cypermethrin. According to the reporter, the product was applied to the patient's home 10 days prior to the report (08/16/2009). The patient left the home at the time of product application and did not return home for 8 hours. At an unknown time following product application, the patient developed several episodes of facial swelling which required treatment at an emergency room. At the time of the report, the patient had angioedema and pneumonia and was being admitted to the hospital. The reporter was advised that the active ingredient is a pyrethroid which are typically diluted when applied. The product can be an irritant to the upper respiratory tract if inhaled and an irritant to the skin if dermal contact with wet product occurs. Once the product has dried, adverse signs are not expected. If the patient did contact wet product, hypersensitivity is possible but is a rare occurrence. Angioedema and pneumonia are not reported events with routine use of the product. The reporter was provided a Material Safety Data Sheet. On follow up on 08/28/2009, a nurse stated that the patient's pneumonia was persistent and that she was coughing up a thick green material. Her lung sounds were diminished but she did not require supplemental oxygen. The patient was receiving respiratory treatments every 6 hours and was afebrile. No further information was obtained.
Majeure
The signs described are not consistent with exposure to dried product residue. Exposure in this case is unknown. Re-entry interval is until dry. Patient did not return for 8 hours, therefore re-entry interval was exceeded and exposure unlikely.